Recent initiatives are welcome but insufficient to solve cross-border trial problems, says Guild group
The EU should do more to support multi-national clinical trials of potential medical treatments, due to difficulties including around the sharing of health data, according to a group of universities.
New EU laws on clinical trials that came into force in January and are intended to make it easier to conduct trials, as well as a new initiative to boost cross-border trials in particular, are welcome but do not go far enough, according to the Guild of European Research-Intensive Universities.
This article is only available to Research Professional News subscribers. If you are a subscriber you can read the article in full on researchprofessional.com
Pivot-RP users can log in and view the article via this link.